FDA NDC Directory · JSON-LD · Markdown

JYLAMVO

NDC 81927-204 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameMethotrexate
Labeler / ManufacturerSHORLA ONCOLOGY INC.
Marketing categoryNew Drug Application (innovator) · App NDA212479
Dosage form / routeSOLUTION · ORAL
Active ingredientsMETHOTREXATE (2 mg/mL)
Marketing started20231215
Package count1

External sources

Source: openFDA. Public-domain (CC0).